National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

MART-1:27-35 peptide vaccine
A natural or synthetic peptide cancer vaccine consisting of amino acid residues 27 through 35 of the melanoma-associated antigen MART-1 with potential antineoplastic activity. Vaccination with MART-1:27-35 peptide may induce cytotoxic host immune responses against melanoma cells that express this peptide. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)




Previous:marijuana, marimastat, Marinol, MART-1 antigen, MART-1:26-35(27L) peptide vaccine
Next:mast cell stabilizer TF002, Matulane, matuzumab, Maxidex, Maxipime

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov